Navigation Links
New Zealand Wayne's New Resources Development Co., Ltd. Completes Reverse Merger to Go Public in the U.S.

HARBIN, China, Dec. 30 /PRNewswire-Asia-FirstCall/ -- YzApp International Inc. (the "Company" or "YzApp") (OTC Bulletin Board: YZPI) announced that it has successfully closed a share exchange transaction with the shareholder of New Zealand WAYNE's New Resources Development Co., Ltd., a British Virgin Islands corporation ("New Resources"). YzApp will operate through its consolidated indirect Chinese subsidiaries to execute upon the current business plan of those subsidiaries.

In the share exchange transaction, New Resources' shareholder was issued 689,390 shares of the Company's Series A Voting Convertible Preferred Stock in exchange 100% of the issued and outstanding shares of New Resources. On an as- converted to common stock basis, the shares of Series A Voting Convertible Preferred Stock received by the shareholder of New Resources represent approximately 94% of the total issued and outstanding capital stock of the Company.

As a result of the share exchange transaction, New Resources has become a wholly-owned subsidiary of the Company. Ms. Lianyuan Han was appointed to the Board of Directors of the Company and the Company's executive officers were replaced by the executive officers of New Resources and its subsidiaries upon the closing of the share exchange. The Company's shares are listed on the Over-the-Counter Bulletin Board ("OTCBB") under the symbol, YZPI.OB.

    The Company plans to amend its Articles of Incorporation to:

     -- change the name of the Company to Shuaiyi International New
        Resources Development Inc.;
     -- increase its authorized common stock to 190,000,000 shares; and
     -- effectuate a 1-for 114.59 reverse stock split of the Company's
        outstanding shares of common stock.

After the amendment of the Company's Articles of Incorporation, which is expected to become effective in or about January 2009, the outstanding shares of Series A Voting Convertible Preferred Stock will convert into shares of common stock on a 2000-to-1 basis and, thereafter, are subject to the 1-to- 114.59 reverse split. Following the effectiveness of the reverse split and the conversion of Series A Preferred Stock into common stock, there will be approximately 12,800,297 shares of the Company's common stock issued and outstanding.

"We are delighted to have successfully closed the going public transaction," said Lianyun Han, the new Chief Executive Officer of YzApp. "Even though the current financial environment is quite challenging, we haven't seen any material adverse impact on our business by the economic downturn at the moment, and we are very confident of the Company's continuing solid growth. We believe that OTCBB provides us with a good trading platform that will eventually lead the Company to upgrade to a national exchange."

Through its Chinese subsidiaries, YzApp now is a leading Chinese Caterpillar Fungus grower and producer in China. The Company specializes in developing, processing, marketing and distributing a variety of high-tech agricultural and nutraceutical products consist of dry Chinese Caterpillar Fungus, Green and Specialty food products and Silage Fodder. The Company's current primary product, dry Chinese Caterpillar Fungus, is developed from Cordyceps Militaris, which is a fungus species that is widely believed in China to offer high medical and health benefits. In addition, the Company plans to introduce more products developed from Chinese Caterpillar Fungus to the market within the coming months and years, including Cordycepin and Corn Series Beverage. The Company's audited net income for 2006 and 2007 are approximately $1.66 million and $5.17 million, respectively, and the unaudited net income and total shareholder's equity for the first nine month in 2008 are approximately $4.87 million and $21.47 million, respectively.

Forward-looking Statement

This press release contains certain forward-looking statement relating to the business of YzApp and its subsidiary companies. All statements other than statements of historical fact included herein are "forward-looking statements". These forward looking statements are often identified by the use of forward- looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website ( ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

SOURCE YzApp International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
2. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
3. OptumHealth Launched, Health and Wellness Information Destination with Clinically Reviewed Content, Tools and Resources
4. Blue Cross Names New Chief Information Officer; Senior Vice President, Human Resources and Facilities
5. Newport Introduces More Resources for Spanish Speaking Plan Participants
6. All Nursing Schools Offers Continuing Education Resources
7. NJHA: Hospital Needs Exceed Stabilization Fund Resources
8. Hospira Names Ken Meyers to Lead Human Resources
9. Decision Resources White Paper Discusses Increasing Reality of Biosimilars and their Impact on Biologics Market
10. New State Public Health Department Survey Results Highlight Available Resources for Men and Women
11. Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: